共 50 条
Longterm Treatment with Endothelin Receptor Antagonist Bosentan and Iloprost Improves Fingertip Blood Perfusion in Systemic Sclerosis
被引:53
|作者:
Cutolo, Maurizio
[1
]
Ruaro, Barbara
[1
,2
]
Pizzorni, Carmen
[1
,2
]
Ravera, Francesca
[1
,2
]
Smith, Vanessa
[3
]
Zampogna, Giuseppe
[1
,2
]
Paolino, Sabrina
[1
,2
]
Seriolo, Bruno
[1
,2
]
Cimmino, Marco
[1
,2
]
Sulli, Alberto
[1
,2
]
机构:
[1] Univ Genoa, Res Lab, I-16132 Genoa, Italy
[2] Univ Genoa, Acad Div Clin Rheumatol, Dept Internal Med, I-16132 Genoa, Italy
[3] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium
关键词:
SYSTEMIC SCLEROSIS;
RAYNAUD PHENOMENON;
LASER DOPPLER FLOWMETRY;
NAILFOLD VIDEOCAPILLAROSCOPY;
ENDOTHELIN-1;
ANTAGONIST;
ILOPROST;
RAYNAUDS-PHENOMENON;
NAILFOLD VIDEOCAPILLAROSCOPY;
CAPILLAROSCOPIC ANALYSIS;
MICROVASCULAR CHANGES;
DISEASE;
MANAGEMENT;
SEVERITY;
DAMAGE;
D O I:
10.3899/jrheum.131284
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objective. To evaluate the longterm effects of endothelin-1 (ET-1) antagonism on peripheral blood perfusion (PBP) in patients with systemic sclerosis (SSc). Methods. Twenty-six patients with SSc already receiving cyclic intravenous iloprost (ILO) for severe Raynaud phenomenon were enrolled. Thirteen patients continued the treatment for a further 3 years (ILO group) and 13 patients, because of the appearance of digital ulcers, received in addition bosentan (BOS; 125 mg twice/day) for 3 years (ILO + BOS group). Both PBP at fingertips and nailfold microangiopathy were evaluated yearly by laser Doppler flowmetry and nailfold videocapillaroscopy, respectively. Results. A progressive significant increase of PBP was observed in the ILO + BOS group during the 3 followup years (p = 0.0007, p = 0.0002, p = 0.01, respectively). In contrast, an insignificant progressive decrease of PBP was observed in the ILO group. Difference of perfusion between the PBP evaluations at basal temperature and at 36 degrees C (to test capillary dilation capacity), was found progressively decreased during the 3-year followup only in the ILO group (p = 0.05, p = 0.26, p = 0.09, respectively). A progressive increase of nailfold capillary number was observed only in the ILO + BOS group after 2 and 3 years of followup (p = 0.05). Conclusion. Longterm treatment of SSc patients with ET-1 antagonism, in combination with ILO, seems to increase fingertip blood perfusion, as well as both capillary dilation capacity and number.
引用
收藏
页码:881 / 886
页数:6
相关论文